Cullinan Therapeutics, Inc. (CGEM)
(Delayed Data from NSDQ)
$18.89 USD
+2.22 (13.32%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $18.88 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.88 | 6.46% |
Earnings Summary
For their last quarter, Cullinan Therapeutics, Inc. (CGEM) reported earnings of -$0.54 per share, beating the Zacks Consensus Estimate of $-0.96 per share. This reflects a positive earnings surprise of 43.75%. Look out for CGEM's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.88 per share, reflecting a year-over-year increase of 38.03%.
Earnings History
Price & Consensus
Zacks News for CGEM
Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
CGEM: What are Zacks experts saying now?
Zacks Private Portfolio Services